Wayspring, a company specializing in value-based care for substance use disorder (SUD) populations, has announced a new capital raise led by CVS Health Ventures. This funding round also saw the participation of existing investors such as Valtruis, HLM Venture Partners, and .406 Ventures. The capital will be used to expand Wayspring’s SUD Home program into new markets, enhancing healthcare delivery by integrating clinical care with a deep understanding of social determinants of health (SDOH). Wayspring’s CEO, Carter Paine, highlighted the collaborative effort to make patient-centered care more accessible. Wayspring’s innovative care model aims to improve health outcomes and reduce costs, partnering with health plans across eight states and planning to launch its services in two new states in 2024.

Healthcare, Venture Capital, Technology,United States